Atrium Therapeutics, Inc. RNA
8.64 USD -0.08 (-0.92%)
Nov 4, 2026, 3:43 PM EST
8.50 Day range 8.90
7.49 52-week range 16.77
- YTD
- -41.42%
- 1 year
- -41.42%
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2025 | Chardan Capital | Maintained | Neutral | Neutral |
| Oct 29, 2025 | TD Cowen | Downgrade | Buy | Hold |
| Oct 28, 2025 | Chardan Capital | Downgrade | Buy | Neutral |
| Oct 28, 2025 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Oct 27, 2025 | Citigroup | Downgrade | Buy | Neutral |
| Oct 27, 2025 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Oct 27, 2025 | Raymond James | Downgrade | Strong Buy | Market Perform |
| Oct 27, 2025 | Bernstein | Downgrade | Outperform | Market Perform |
| Oct 27, 2025 | Needham | Downgrade | Buy | Hold |
| Oct 27, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Sep 22, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Sep 17, 2025 | Roth Capital | Initiated | — | Buy |
| Sep 15, 2025 | B of A Securities | Maintained | Buy | Buy |
| Sep 12, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 10, 2025 | Needham | Maintained | Buy | Buy |
| Sep 10, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Aug 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 8, 2025 | Barclays | Maintained | Overweight | Overweight |
| Aug 8, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Jun 27, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 17, 2025 | Wolfe Research | Initiated | — | Outperform |
| Jun 11, 2025 | Raymond James | Initiated | — | Strong Buy |
| Jun 10, 2025 | Citigroup | Maintained | Buy | Buy |
| Jun 10, 2025 | Barclays | Maintained | Overweight | Overweight |
| Jun 9, 2025 | B of A Securities | Maintained | Buy | Buy |
| Jun 9, 2025 | Chardan Capital | Maintained | Buy | Buy |
| May 12, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 9, 2025 | Chardan Capital | Maintained | Buy | Buy |
| May 7, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Apr 9, 2025 | Needham | Reiterated | Buy | Buy |
